Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX

The Vanguard Group reported a 5.04% stake in Amylyx Pharmaceuticals, Inc. (Schedule 13G)

Event Jun 30, 2025 · Filed Jul 29, 2025

The Vanguard Group reported a 5.04% stake in Amylyx Pharmaceuticals, Inc., 4,498,028 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G).

Stake
5.04%
Shares
4,498,028
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
The Vanguard Group5.04%4,498,028

Source

View original at SEC

Related